Salzer Electronics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 16, 2025, 2:35 pm

Competitors of Salzer Electronics Ltd

All Competitor Stocks of Salzer Electronics Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:54 am

Below is a detailed analysis of the quarterly data for Salzer Electronics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 365.59 Cr.. The value appears strong and on an upward trend. It has increased from 333.82 Cr. (Dec 2024) to 365.59 Cr., marking an increase of 31.77 Cr..
• For Expenses, as of Mar 2025, the value is 339.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 299.48 Cr. (Dec 2024) to 339.41 Cr., marking an increase of 39.93 Cr..
• For Operating Profit, as of Mar 2025, the value is 26.18 Cr.. The value appears to be declining and may need further review. It has decreased from 34.34 Cr. (Dec 2024) to 26.18 Cr., marking a decrease of 8.16 Cr..
• For OPM %, as of Mar 2025, the value is 7.16%. The value appears to be declining and may need further review. It has decreased from 10.29% (Dec 2024) to 7.16%, marking a decrease of 3.13%.
• For Other Income, as of Mar 2025, the value is 1.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.93 Cr. (Dec 2024) to 1.77 Cr., marking a decrease of 0.16 Cr..
• For Interest, as of Mar 2025, the value is 10.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.49 Cr. (Dec 2024) to 10.60 Cr., marking an increase of 0.11 Cr..
• For Depreciation, as of Mar 2025, the value is 5.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.88 Cr. (Dec 2024) to 5.70 Cr., marking a decrease of 0.18 Cr..
• For Profit before tax, as of Mar 2025, the value is 11.65 Cr.. The value appears to be declining and may need further review. It has decreased from 19.90 Cr. (Dec 2024) to 11.65 Cr., marking a decrease of 8.25 Cr..
• For Tax %, as of Mar 2025, the value is 29.36%. The value appears to be increasing, which may not be favorable. It has increased from 26.78% (Dec 2024) to 29.36%, marking an increase of 2.58%.
• For Net Profit, as of Mar 2025, the value is 8.23 Cr.. The value appears to be declining and may need further review. It has decreased from 14.57 Cr. (Dec 2024) to 8.23 Cr., marking a decrease of 6.34 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.65. The value appears to be declining and may need further review. It has decreased from 8.24 (Dec 2024) to 4.65, marking a decrease of 3.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:15 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:25 am

Below is a detailed analysis of the balance sheet data for Salzer Electronics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 513.00 Cr.. The value appears strong and on an upward trend. It has increased from 449.00 Cr. (Mar 2024) to 513.00 Cr., marking an increase of 64.00 Cr..
• For Borrowings, as of Mar 2025, the value is 418.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 308.00 Cr. (Mar 2024) to 418.00 Cr., marking an increase of 110.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 217.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 196.00 Cr. (Mar 2024) to 217.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,165.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 970.00 Cr. (Mar 2024) to 1,165.00 Cr., marking an increase of 195.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 254.00 Cr. (Mar 2024) to 295.00 Cr., marking an increase of 41.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 841.00 Cr.. The value appears strong and on an upward trend. It has increased from 689.00 Cr. (Mar 2024) to 841.00 Cr., marking an increase of 152.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,165.00 Cr.. The value appears strong and on an upward trend. It has increased from 970.00 Cr. (Mar 2024) to 1,165.00 Cr., marking an increase of 195.00 Cr..

Notably, the Reserves (513.00 Cr.) exceed the Borrowings (418.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Salzer Electronics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 35.30. This value is within the healthy range. It has increased from 27.38 (Mar 24) to 35.30, marking an increase of 7.92.
• For Diluted EPS (Rs.), as of Mar 25, the value is 35.21. This value is within the healthy range. It has increased from 25.94 (Mar 24) to 35.21, marking an increase of 9.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 42.92. This value is within the healthy range. It has increased from 38.65 (Mar 24) to 42.92, marking an increase of 4.27.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 307.95. It has increased from 272.38 (Mar 24) to 307.95, marking an increase of 35.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 307.95. It has increased from 272.38 (Mar 24) to 307.95, marking an increase of 35.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 802.10. It has increased from 670.96 (Mar 24) to 802.10, marking an increase of 131.14.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 78.74. This value is within the healthy range. It has increased from 68.42 (Mar 24) to 78.74, marking an increase of 10.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 65.50. This value is within the healthy range. It has increased from 56.85 (Mar 24) to 65.50, marking an increase of 8.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.23. This value is within the healthy range. It has increased from 37.24 (Mar 24) to 42.23, marking an increase of 4.99.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 29.68. This value is within the healthy range. It has increased from 27.08 (Mar 24) to 29.68, marking an increase of 2.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 26.03. This value is within the healthy range. It has decreased from 26.39 (Mar 24) to 26.03, marking a decrease of 0.36.
• For PBDIT Margin (%), as of Mar 25, the value is 9.81. This value is below the healthy minimum of 10. It has decreased from 10.19 (Mar 24) to 9.81, marking a decrease of 0.38.
• For PBIT Margin (%), as of Mar 25, the value is 8.16. This value is below the healthy minimum of 10. It has decreased from 8.47 (Mar 24) to 8.16, marking a decrease of 0.31.
• For PBT Margin (%), as of Mar 25, the value is 5.26. This value is below the healthy minimum of 10. It has decreased from 5.54 (Mar 24) to 5.26, marking a decrease of 0.28.
• For Net Profit Margin (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has decreased from 4.03 (Mar 24) to 3.70, marking a decrease of 0.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.24. This value is below the healthy minimum of 8. It has decreased from 3.93 (Mar 24) to 3.24, marking a decrease of 0.69.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.45. This value is below the healthy minimum of 15. It has decreased from 9.68 (Mar 24) to 8.45, marking a decrease of 1.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.11. This value is within the healthy range. It has increased from 18.89 (Mar 24) to 19.11, marking an increase of 0.22.
• For Return On Assets (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 5. It has decreased from 4.61 (Mar 24) to 3.90, marking a decrease of 0.71.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.77. This value is within the healthy range. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has increased from 1.24 (Mar 24) to 1.31, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 1.5. It has decreased from 1.50 (Mar 24) to 1.47, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.83, marking a decrease of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.28. This value is below the healthy minimum of 4. It has increased from 3.13 (Mar 24) to 3.28, marking an increase of 0.15.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.00 (Mar 24) to 0.00, marking a decrease of 8.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.56 (Mar 24) to 0.00, marking a decrease of 5.56.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.00 (Mar 24) to 0.00, marking a decrease of 92.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.44 (Mar 24) to 0.00, marking a decrease of 94.44.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.38. This value is within the healthy range. It has decreased from 3.49 (Mar 24) to 3.38, marking a decrease of 0.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 2.28, marking a decrease of 0.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,322.61. It has increased from 1,759.93 (Mar 24) to 2,322.61, marking an increase of 562.68.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.64, marking an increase of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is 16.68. This value exceeds the healthy maximum of 15. It has increased from 14.80 (Mar 24) to 16.68, marking an increase of 1.88.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.34, marking an increase of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.99 (Mar 24) to 0.00, marking a decrease of 91.99.
• For Price / BV (X), as of Mar 25, the value is 3.49. This value exceeds the healthy maximum of 3. It has increased from 3.08 (Mar 24) to 3.49, marking an increase of 0.41.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.34, marking an increase of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness